Literature DB >> 16025518

Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors.

Steven C Katz1, Venu G Pillarisetty, Joshua I Bleier, T Peter Kingham, Umer I Chaudhry, Alaap B Shah, Ronald P DeMatteo.   

Abstract

The contribution of intrahepatic conventional T cells to the unique immunologic properties of the liver has not been clearly defined. We isolated bulk and CD4 T cells from mouse liver and compared their functions with each other and with their splenic counterparts. Unlike bulk spleen T cells, bulk liver T cells reacted minimally to allogeneic or antigen-loaded syngeneic dendritic cells. However, after exclusion of natural killer T cells (NKTs) and gammadelta T cells by FACS, liver and spleen CD4 T cells actually proliferated to a similar extent upon allogeneic or antigen-specific stimulation. Liver CD4 T cells were more sensitive to interleukin 2 (IL-2) than were spleen CD4 T cells, but had a similar proliferative potential based on their response to CD3 ligation. In addition, activated liver CD4 T cells produced higher levels of IL-4, IL-5, IL-10, and interferon gamma (IFN-gamma) than did splenic CD4 T cells. Therefore, liver CD4 T cells are intrinsically different from spleen CD4 T cells. In vitro, liver or spleen NKTs and gammadelta T cells suppressed liver and spleen CD4 T-cell proliferation in a dose-dependent fashion. In conclusion, unconventional T cells constrain liver CD4 T-cell function. Our findings have implications for pathological conditions of the liver that involve the response of conventional CD4 T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025518     DOI: 10.1002/hep.20795

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses.

Authors:  S-A Shu; Z-X Lian; Y-H Chuang; G-X Yang; Y Moritoki; S S Comstock; R-Q Zhong; A A Ansari; Y-J Liu; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

2.  HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases.

Authors:  Steven C Katz; John Hardaway; Ethan Prince; Prajna Guha; Marissa Cunetta; Ashley Moody; Li Juan Wang; Vincent Armenio; N Joseph Espat; Richard P Junghans
Journal:  Cancer Gene Ther       Date:  2019-06-03       Impact factor: 5.987

3.  Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.

Authors:  Rachel A Burga; Mitchell Thorn; Gary R Point; Prajna Guha; Cang T Nguyen; Lauren A Licata; Ronald P DeMatteo; Alfred Ayala; N Joseph Espat; Richard P Junghans; Steven C Katz
Journal:  Cancer Immunol Immunother       Date:  2015-04-08       Impact factor: 6.968

4.  Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Authors:  Steven C Katz; Rachel A Burga; Elise McCormack; Li Juan Wang; Wesley Mooring; Gary R Point; Pranay D Khare; Mitchell Thorn; Qiangzhong Ma; Brian F Stainken; Earle O Assanah; Robin Davies; N Joseph Espat; Richard P Junghans
Journal:  Clin Cancer Res       Date:  2015-04-07       Impact factor: 12.531

5.  Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Authors:  Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz
Journal:  J Leukoc Biol       Date:  2013-07-24       Impact factor: 4.962

6.  Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

Authors:  Steven C Katz; Zubin M Bamboat; Ajay V Maker; Jinru Shia; Venu G Pillarisetty; Adam C Yopp; Cyrus V Hedvat; Mithat Gonen; William R Jarnagin; Yuman Fong; Michael I D'Angelica; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2012-09-26       Impact factor: 5.344

7.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

8.  Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.

Authors:  M Thorn; P Guha; M Cunetta; N J Espat; G Miller; R P Junghans; S C Katz
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

9.  Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Authors:  Mitchell Thorn; Gary R Point; Rachel A Burga; Cang T Nguyen; N Joseph Espat; Steven C Katz
Journal:  J Leukoc Biol       Date:  2014-08-01       Impact factor: 4.962

Review 10.  The prognostic value of liver tumor T cell infiltrates.

Authors:  Hadi Khan; Venu G Pillarisetty; Steven C Katz
Journal:  J Surg Res       Date:  2014-06-07       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.